vs
BALCHEM CORP（BCPC）与SOLAREDGE TECHNOLOGIES, INC.（SEDG）财务数据对比。点击上方公司名可切换其他公司
SOLAREDGE TECHNOLOGIES, INC.的季度营收约是BALCHEM CORP的1.3倍（$335.4M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs -39.4%，领先54.3%），SOLAREDGE TECHNOLOGIES, INC.同比增速更快（70.9% vs 9.8%），过去两年SOLAREDGE TECHNOLOGIES, INC.的营收复合增速更高（28.1% vs 4.9%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
SolarEdge Technologies是一家以色列新能源科技企业，核心研发并推出了直流优化逆变器系统，该方案可提升光伏发电的能效表现，助力光伏系统实现更稳定、高效的电力转换，在全球分布式光伏领域拥有广泛的应用场景和市场认可度。
BCPC vs SEDG — 直观对比
营收规模更大
SEDG
是对方的1.3倍
$263.6M
营收增速更快
SEDG
高出61.1%
9.8%
净利率更高
BCPC
高出54.3%
-39.4%
两年增速更快
SEDG
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $335.4M |
| 净利润 | $39.2M | $-132.1M |
| 毛利率 | 35.6% | 22.2% |
| 营业利润率 | 19.8% | -14.4% |
| 净利率 | 14.9% | -39.4% |
| 营收同比 | 9.8% | 70.9% |
| 净利润同比 | 16.8% | 54.0% |
| 每股收益（稀释后） | $1.21 | $-2.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCSEDG
| Q4 25 | $263.6M | $335.4M | ||
| Q3 25 | $267.6M | $340.2M | ||
| Q2 25 | $255.5M | $289.4M | ||
| Q1 25 | $250.5M | $219.5M | ||
| Q4 24 | $240.0M | $196.2M | ||
| Q3 24 | $239.9M | $235.4M | ||
| Q2 24 | $234.1M | $265.4M | ||
| Q1 24 | $239.7M | $204.4M |
净利润BCPCSEDG
| Q4 25 | $39.2M | $-132.1M | ||
| Q3 25 | $40.3M | $-50.1M | ||
| Q2 25 | $38.3M | $-124.7M | ||
| Q1 25 | $37.1M | $-98.5M | ||
| Q4 24 | $33.6M | $-287.4M | ||
| Q3 24 | $33.8M | $-1.2B | ||
| Q2 24 | $32.1M | $-130.8M | ||
| Q1 24 | $29.0M | $-157.3M |
毛利率BCPCSEDG
| Q4 25 | 35.6% | 22.2% | ||
| Q3 25 | 35.7% | 21.2% | ||
| Q2 25 | 36.4% | 11.1% | ||
| Q1 25 | 35.2% | 8.0% | ||
| Q4 24 | 36.0% | -57.2% | ||
| Q3 24 | 35.6% | -309.1% | ||
| Q2 24 | 35.5% | -4.1% | ||
| Q1 24 | 34.0% | -12.8% |
营业利润率BCPCSEDG
| Q4 25 | 19.8% | -14.4% | ||
| Q3 25 | 20.4% | -10.3% | ||
| Q2 25 | 20.1% | -39.9% | ||
| Q1 25 | 20.4% | -46.8% | ||
| Q4 24 | 19.8% | -134.4% | ||
| Q3 24 | 20.0% | -471.8% | ||
| Q2 24 | 19.6% | -60.4% | ||
| Q1 24 | 17.4% | -85.0% |
净利率BCPCSEDG
| Q4 25 | 14.9% | -39.4% | ||
| Q3 25 | 15.1% | -14.7% | ||
| Q2 25 | 15.0% | -43.1% | ||
| Q1 25 | 14.8% | -44.9% | ||
| Q4 24 | 14.0% | -146.5% | ||
| Q3 24 | 14.1% | -522.8% | ||
| Q2 24 | 13.7% | -49.3% | ||
| Q1 24 | 12.1% | -77.0% |
每股收益（稀释后）BCPCSEDG
| Q4 25 | $1.21 | $-2.21 | ||
| Q3 25 | $1.24 | $-0.84 | ||
| Q2 25 | $1.17 | $-2.13 | ||
| Q1 25 | $1.13 | $-1.70 | ||
| Q4 24 | $1.03 | $-5.00 | ||
| Q3 24 | $1.03 | $-21.58 | ||
| Q2 24 | $0.98 | $-2.31 | ||
| Q1 24 | $0.89 | $-2.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $493.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $427.5M |
| 总资产 | $1.7B | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCSEDG
| Q4 25 | $74.6M | $493.2M | ||
| Q3 25 | $65.1M | $498.6M | ||
| Q2 25 | $65.4M | $758.0M | ||
| Q1 25 | $49.9M | $651.6M | ||
| Q4 24 | $49.5M | $585.9M | ||
| Q3 24 | $73.7M | $678.8M | ||
| Q2 24 | $63.7M | $689.8M | ||
| Q1 24 | $60.3M | $680.6M |
股东权益BCPCSEDG
| Q4 25 | $1.3B | $427.5M | ||
| Q3 25 | $1.3B | $479.8M | ||
| Q2 25 | $1.3B | $513.2M | ||
| Q1 25 | $1.2B | $594.2M | ||
| Q4 24 | $1.1B | $658.3M | ||
| Q3 24 | $1.2B | $930.9M | ||
| Q2 24 | $1.1B | $2.1B | ||
| Q1 24 | $1.1B | $2.2B |
总资产BCPCSEDG
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $2.5B | ||
| Q1 25 | $1.6B | $2.5B | ||
| Q4 24 | $1.6B | $2.6B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.6B | $3.9B | ||
| Q1 24 | $1.6B | $4.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $52.6M |
| 自由现金流经营现金流 - 资本支出 | — | $43.3M |
| 自由现金流率自由现金流/营收 | — | 12.9% |
| 资本支出强度资本支出/营收 | — | 2.8% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $80.8M |
8季度趋势，按日历期对齐
经营现金流BCPCSEDG
| Q4 25 | $67.3M | $52.6M | ||
| Q3 25 | $65.6M | $25.6M | ||
| Q2 25 | $47.3M | $-7.8M | ||
| Q1 25 | $36.5M | $33.8M | ||
| Q4 24 | $52.3M | $37.8M | ||
| Q3 24 | $51.3M | $-89.3M | ||
| Q2 24 | $45.0M | $-44.8M | ||
| Q1 24 | $33.4M | $-217.0M |
自由现金流BCPCSEDG
| Q4 25 | — | $43.3M | ||
| Q3 25 | — | $22.8M | ||
| Q2 25 | — | $-9.1M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $25.5M | ||
| Q3 24 | — | $-136.7M | ||
| Q2 24 | — | $-67.0M | ||
| Q1 24 | — | $-243.4M |
自由现金流率BCPCSEDG
| Q4 25 | — | 12.9% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | -3.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | -58.1% | ||
| Q2 24 | — | -25.2% | ||
| Q1 24 | — | -119.1% |
资本支出强度BCPCSEDG
| Q4 25 | — | 2.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 4.6% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 12.9% |
现金转化率BCPCSEDG
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
SEDG
| Other | $197.7M | 59% |
| Europe Except Netherlands | $99.4M | 30% |
| Others | $38.2M | 11% |
